Delivery Order SPE2DB20D3101-SPE2DB20FH0W0
- Not listed
- This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, to serve as a prime vendor for pharmaceutical products and medical supplies. The contract, valued at $1,039.11, is a delivery order under an Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical worth up to $999,999,999.00. The contract covers a broad range of essential medical commodities, including...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, to serve as a prime vendor for pharmaceutical products and medical supplies. The contract, valued at $1,676.19, is a delivery order under an Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which has a ceiling value of $999,999,999.00 and runs through November 2026. This IDC enables the DLA to...
- This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, to serve as a prime vendor for pharmaceutical products and medical supplies. The contract has a ceiling value of $2,167.06 and is a delivery order under a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00 and running through November 2026. This IDC enables the...
- This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, to serve as a prime vendor for pharmaceutical products and medical supplies. The contract, valued at $1,047.01, is a delivery order that runs through November 2020. It is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical, valued at up to $999,999,999.00 and lasting through November 2026. This...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distribution company, to provide a prime vendor pharmaceutical supply service to the DLA's Troop Support Medical branch. The contract, valued at $9,573.84, is a delivery order awarded under an Indefinite Delivery Contract (IDC) worth up to $999,999,999.00 that runs through November 2026. The IDC enables the DLA to efficiently procure a comprehensive range of...
- This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, to serve as a prime vendor for pharmaceutical products. The contract, valued at $8,865.33, is a delivery order under an Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which has a ceiling value of $999,999,999.00 and runs through November 2026. This IDC enables the DLA to efficiently procure a comprehensive range of pharmaceutical...
- This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, to serve as a prime vendor for pharmaceutical products and medical supplies. The contract, valued at $1,504.14, is a delivery order with a firm fixed price under an Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA Troop Support Medical, valued at up to $999,999,999.00 and running through...
- This federal contract award is for a pharmaceutical prime vendor contract to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, awarded by the Defense Logistics Agency (DLA), is a Delivery Order under an Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00 through November 2026. The contract covers the delivery of a comprehensive range of pharmaceutical products and medical supplies, including specialty medications,...
- This federal contract award is to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, to provide a prime vendor service for pharmaceutical products to the Defense Logistics Agency (DLA). The contract, valued at $8,086.70, is a delivery order under a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at up to $999,999,999.00 through November 2026. This IDC allows the DLA to efficiently procure a comprehensive range of pharmaceutical products and...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, to serve as a prime vendor for pharmaceutical and medical supplies. The contract, valued at $32,917.02, is a delivery order under a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, worth up to $999,999,999.00 and running through November 2026. This IDC enables the DLA to efficiently procure a comprehensive range of...
- SPE2DB20D3101Indefinite Delivery Contract
- SPE2DB20D3101-SPE2DB20FH0W0Delivery Order
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a pharmaceutical distribution and healthcare solutions provider, to serve as a prime vendor for pharmaceutical products and medical supplies. The contract, valued at $1,260.32, is a delivery order under a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, worth up to $999,999,999.00 and running through November 2026. This IDC enables DLA to efficiently procure a comprehensive range of pharmaceutical and medical commodities, including specialty medications, brand-name and generic drugs, vaccines, syringes, and other critical care items to support military treatment facilities, veterans' healthcare programs, and other federal medical institutions. The contract award does not have a set-aside designation, indicating it was competitively awarded. Amerisourcebergen Drug Corp is a subsidiary of the parent company, Cencora, Inc., which also holds a separate IDC with the Department of Justice Federal Bureau of Investigation, valued at up to $750,000 through May 2024, for similar medical products and prescription drugs.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.3k | 9/16/20 |